Feb 2026 (Q4 FY26) — Jul 14, 2026
Aehr Test Systems Q4 FY26 — Record Bookings and Strong FY27 Outlook Driven by AI and Data Center Demand
Read the full callAehr Test Systems (AEHR) earnings
- May 2026
- Feb 2026 (Q4 FY26)
- May 2026
Aehr Test Systems earnings: last reported Tue, 14 Jul 2026, for the quarter ended Feb 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 18.8 | +33.7% YoY | Quarterly, as filed | Quarter to May 2026 | Revenue from operations as filed. |
| Operating margin | -6.4 | +16.3 pts YoY | Operating profit / revenue | Quarter to May 2026 | For the quarter; a change is in percentage points. |
| Net profit | 1.4 | Quarterly, as filed | Quarter to May 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$63.33 +4.50% · +$2.73
Performance +155.8% 1Y
1Y: $24.76 on 17 Oct 2025 → $63.33. High $145.61 (17 Aug 2026), low $19.4 (20 Nov 2025).
- Previous close
- $60.6
- 52-week range
- $19.4 – $145.61
- One year
- +119.90%
Overview
- Symbol
- AEHR
- Sector
- Information Technology
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Aehr Test Systems earnings calls (AEHR)
Financials
What the filings say
Net profit, year on year: +148% (quarter to may 2026 against may 2025).
| Line item | Aug 2024 | Nov 2024 | Feb 2025 | May 2025 | Aug 2025 | Nov 2025 | Feb 2026 | May 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | — | 13 | 18 | 14 | 11 | 10 | 10 | 19 |
| Operating profit | — | -2 | -1 | -3 | -4 | -5 | -4 | -1 |
| Operating margin | — | −11.3% | −6.1% | −22.7% | −37.1% | −47.0% | −41.0% | −6.4% |
| Profit before tax | — | -1 | -1 | -3 | -3 | -4 | -4 | -0 |
| Tax rate | — | 17.4% | 26.4% | 2.9% | 26.5% | 27.3% | 19.9% | 405.7% |
| Net profit | 1 | -1 | -1 | -3 | -2 | -3 | -3 | 1 |
| EPS ($ per share) | 0.02 | -0.03 | -0.02 | — | -0.07 | -0.11 | -0.10 | — |
| Line item | May 2019 | May 2020 | May 2021 | May 2022 | May 2023 | May 2024 | May 2025 | May 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -71 | -74 | -76 | -67 | -52 | -19 | -23 | -30 |
| Total liabilities | 6 | 7 | 10 | 11 | 23 | 16 | 26 | 27 |
| Fixed assets | 1 | 1 | 1 | 1 | 3 | 3 | 9 | 9 |
| Investments | — | — | — | — | 18 | 0 | — | — |
| Total assets | 21 | 21 | 22 | 62 | 98 | 128 | 149 | 247 |
| Line item | May 2019 | May 2020 | May 2021 | May 2022 | May 2023 | May 2024 | May 2025 | May 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -6 | -2 | -3 | 2 | 10 | 2 | -7 | -3 |
| Cash from investing | -0 | -0 | -0 | -0 | -19 | 17 | -16 | -4 |
| Cash from financing | -6 | 2 | 2 | 26 | 7 | 0 | 1 | 97 |
| Net cash flow | -11 | 0 | -1 | 27 | -1 | 19 | -23 | 90 |
| Capital expenditure | -0 | -0 | -0 | -0 | -1 | -1 | -5 | -2 |
| Free cash flow | -6 | -2 | -3 | 1 | 9 | 1 | -12 | -5 |
Insider filings
239 filings between Oct 20, 2025 and Oct 12, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$59.62M
67 sales by 12 insiders
Compensation
not trading decisions- 20
- Award — granted as compensation
- 9
- Option exercise — converted options into shares
- 113
- Tax withheld — shares kept back by the company to cover tax
Also filed: 16 other filings, 14 gifts.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Erickson Gayn | — | $16.02M | Aug 12, 2026 |
| SCOTT GEOFFREY GATES | — | $12.31M | Aug 12, 2026 |
| POSEDEL RHEA J | — | $9.55M | Aug 14, 2026 |
| SLAYEN HOWARD T | — | $5.20M | Aug 14, 2026 |
| SALAMONE ALBERTO | — | $4.00M | Aug 13, 2026 |
| ROGERS VERNON | — | $3.32M | Aug 17, 2026 |
| ENGINEER ADIL | — | $3.10M | Aug 12, 2026 |
| RICHMOND DONALD P. II | — | $2.33M | Apr 14, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 12, 2026 | Siu Chris CFO | Tax withheld | 987 | $83.5K |
| Oct 12, 2026 | RICHMOND DONALD P. II CTO | Tax withheld | 388 | $32.8K |
| Oct 12, 2026 | Erickson Gayn President and CEO | Tax withheld | 2,675 | $226.4K |
| Oct 12, 2026 | ROGERS VERNON Exec VP of Sales & Mktg. | Tax withheld | 426 | $36.1K |
| Oct 12, 2026 | ENGINEER ADIL Chief Operating Officer | Tax withheld | 547 | $46.3K |
| Oct 12, 2026 | SPORCK ALISTAIR N VP Contactor Business Unit | Tax withheld | 295 | $25.0K |
| Oct 2, 2026 | ENGINEER ADIL Chief Operating Officer | Tax withheld | 620 | $66.5K |
| Oct 2, 2026 | SALAMONE ALBERTO EVP, PPBI BUSINESS | Tax withheld | 556 | $59.6K |
| Oct 2, 2026 | RICHMOND DONALD P. II CTO | Tax withheld | 439 | $47.1K |
| Oct 2, 2026 | ROGERS VERNON Exec VP of Sales & Mktg. | Tax withheld | 476 | $51.0K |
| Oct 2, 2026 | SPORCK ALISTAIR N VP Contactor Business Unit | Tax withheld | 345 | $37.0K |
| Oct 2, 2026 | Erickson Gayn President and CEO | Tax withheld | 3,239 | $347.3K |
| Oct 2, 2026 | Siu Chris CFO | Tax withheld | 1,164 | $124.8K |
| Oct 1, 2026 | RICHMOND DONALD P. II CTO | Tax withheld | 76 | $7.7K |
| Oct 1, 2026 | SALAMONE ALBERTO EVP, PPBI BUSINESS | Other | 1,512 | $10.1K |
| Oct 1, 2026 | Erickson Gayn President and CEO | Other | 1,053 | $7.0K |
| Oct 1, 2026 | SPORCK ALISTAIR N VP Contactor Business Unit | Tax withheld | 54 | $5.5K |
| Oct 1, 2026 | ROGERS VERNON Exec VP of Sales & Mktg. | Tax withheld | 77 | $7.8K |
| Oct 1, 2026 | WIMMERS DIDIER Executive VP of R&D | Tax withheld | 54 | $5.5K |
| Oct 1, 2026 | SALAMONE ALBERTO EVP, PPBI BUSINESS | Tax withheld | 45 | $4.6K |
| Oct 1, 2026 | RICHMOND DONALD P. II CTO | Other | 1,064 | $7.1K |
| Oct 1, 2026 | ENGINEER ADIL Chief Operating Officer | Tax withheld | 98 | $10.0K |
| Oct 1, 2026 | WIMMERS DIDIER Executive VP of R&D | Other | 1,311 | $8.7K |
| Oct 1, 2026 | SPORCK ALISTAIR N VP Contactor Business Unit | Other | 1,221 | $8.1K |
| Oct 1, 2026 | Erickson Gayn President and CEO | Tax withheld | 499 | $50.7K |
| Oct 1, 2026 | ENGINEER ADIL Chief Operating Officer | Other | 730 | $4.9K |
| Oct 1, 2026 | ROGERS VERNON Exec VP of Sales & Mktg. | Other | 1,626 | $10.8K |
| Oct 1, 2026 | Siu Chris CFO | Other | 1,089 | $7.3K |
| Oct 1, 2026 | Siu Chris CFO | Tax withheld | 194 | $19.7K |
| Sep 3, 2026 | WIMMERS DIDIER Executive VP of R&D | Tax withheld | 317 | $24.2K |
| Sep 1, 2026 | Siu Chris CFO | Tax withheld | 496 | $38.0K |
| Aug 17, 2026 | ROGERS VERNON Exec VP of Sales & Mktg. | Sale | 3,994 | $574.2K |
| Aug 14, 2026 | ROGERS VERNON Exec VP of Sales & Mktg. | Sale | 1,000 | $134.0K |
| Aug 14, 2026 | ROGERS VERNON Exec VP of Sales & Mktg. | Sale | 1,000 | $139.0K |
| Aug 14, 2026 | SLAYEN HOWARD T Director | Sale | 5,700 | $758.3K |
| Aug 14, 2026 | POSEDEL RHEA J Director | Sale | 5,973 | $836.2K |
| Aug 14, 2026 | ENGINEER ADIL Chief Operating Officer | Gift | 500 | $0 |
| Aug 13, 2026 | SALAMONE ALBERTO EVP, PPBI BUSINESS | Sale | 4,200 | $537.6K |
| Aug 13, 2026 | SALAMONE ALBERTO EVP, PPBI BUSINESS | Sale | 5,472 | $697.7K |
| Aug 12, 2026 | POSEDEL RHEA J Director | Sale | 8,413 | $1.09M |
| Aug 12, 2026 | SCOTT GEOFFREY GATES Director | Sale | 20,000 | $2.63M |
| Aug 12, 2026 | SCOTT GEOFFREY GATES Director | Gift | 6,731 | $0 |
| Aug 12, 2026 | ENGINEER ADIL Chief Operating Officer | Sale | 7,500 | $983.2K |
| Aug 12, 2026 | ENGINEER ADIL Chief Operating Officer | Sale | 7,500 | $982.2K |
| Aug 12, 2026 | Erickson Gayn President and CEO | Sale | 1,548 | $204.7K |
| Aug 12, 2026 | ENGINEER ADIL Chief Operating Officer | Option exercise | 15,000 | $141.8K |
| Aug 12, 2026 | Erickson Gayn President and CEO | Sale | 38,452 | $5.03M |
| Aug 12, 2026 | OLIPHANT LAURA Director | Sale | 1,717 | $228.4K |
| Aug 10, 2026 | SPORCK ALISTAIR N VP Contactor Business Unit | Sale | 1,000 | $108.5K |
| Aug 4, 2026 | SPORCK ALISTAIR N VP Contactor Business Unit | Sale | 1,301 | $131.5K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for AEHR TEST SYSTEMS
Free account. Everything above stays public.
Write why you follow AEHR TEST SYSTEMS and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading